Silver Book Fact

One economic model predicts that if type 1 and type 2 diabetics had begun Captopril (a drug that controls blood pressure and delays the onset of kidney failure) treatment in 1995, the aggregate health care cost savings in 1999 would have been $189 million and in 2004 would have been $475 million-a present value cumulative cost savings of $2.4 billion for those 10 years.

Rodby R, Firth L, Lewis E. An Economic Analysis of Captopril in the Treatment of Diabetic Nephropathy. Diabetes Care. 1996; 19(10): 1051-61. http://care.diabetesjournals.org/cgi/content/abstract/19/10/1051

Reference

Title
An Economic Analysis of Captopril in the Treatment of Diabetic Nephropathy
Publication
Diabetes Care
Publication Date
1996
Authors
Rodby R, Firth L, Lewis E
Volume & Issue
Volume 19, Issue 10
Pages
1051-61
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Every additional dollar spent on intensive blood glucose control for newly diagnosed type 2 diabetic patients has produced health gains valued at $3.77.  
  • Blood pressure control in diabetics reduces the risk of cardiovascular disease by 33% to 50%, and the risk of microvascular complications by approximately 33%.  
  • One economic model predicts that if type 1 and type 2 diabetics had begun Captopril (a drug that controls blood pressure and delays the onset of kidney failure) treatment in…  
  • In a study investigating the effectiveness of diabetes management services from clinical pharmacists on patients, based on an estimated savings of $820 for each 1% decrease in A1c, the reduction…  
  • Therapy that keeps blood glucose levels as close to normal as possible in type 1 diabetics, reduces damage to the eyes by 76%. Experts believe that these results can…